Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The DNA damage response (DDR) pathway and ARF function as barriers to cancer development. Although commonly regarded as operating independently of each other, some studies proposed that ARF is positively regulated by the DDR. Contrary to either scenario, we found that in human oncogene-transformed and cancer cells, ATM suppressed ARF protein levels and activity in a transcription-independent manner. Mechanistically, ATM activated protein phosphatase 1, which antagonized Nek2-dependent phosphorylation of nucleophosmin (NPM), thereby liberating ARF from NPM and rendering it susceptible to degradation by the ULF E3-ubiquitin ligase. In human clinical samples, loss of ATM expression correlated with increased ARF levels and in xenograft and tissue culture models, inhibition of ATM stimulated the tumour-suppressive effects of ARF. These results provide insights into the functional interplay between the DDR and ARF anti-cancer barriers, with implications for tumorigenesis and treatment of advanced tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a tight regulatory network in human cancer models was reported, whereby ATM suppresses ARF levels and ARF acts as a secondary barrier to cancer progression when ATM is inactivated31”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [31]
In the citing paper
“DDR precedes ARF engagement, whose activation is detected at later stages of cancer progression and less frequently than DDR”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [31]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Self-citationActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citation
Cited by
Items 101–129 of 129
Molecular genetic response to varied wavelengths of light in Xiphophorus maculatus skin
Chang, J. T., Lü, Y., Boswell, W. T., Boswell, M., Caballero, K. L., & Walter, R. B. (2015) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2015.10.002 · Cited by 11
“Moreover, recent studies indicate that atm and atr co-regulate cell proliferation with p14arf, a secondary tumor suppressor found in human and mouse cells (Carlos et al., 2013; Velimezi et al., 2013).”
BackgroundPTEN ‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells
He, J., Guo, Y., Deng, R., Li, L., Huang, C., Chen, R., Wang, Y., Huang, J. J., Zheng, J., Chen, G., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13563 · Cited by 10
“In addition, ATM, a main DDR kinase, promotes the release of p14ARF from the nucleus and subsequent degradation after doxorubicin treatment [66].”
BackgroundNanomaterials intervene in cell senescence to reinforce cancer therapy
Sun, S., Yang, N., Nie, J., Yang, Z., Pei, Z., Ding, R., & Cheng, L. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217012 · Cited by 10
Spanou, E., Kalisperati, P., Pateras, I. S., Papalampros, A., Barbouti, A., Tzioufas, A. G., Kotsinas, A., & Sougioultzis, S. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00065 · Cited by 10
Self-citationHan, M., Ma, L., Qu, Y., & Tang, Y. C. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.05.012 · Cited by 9
Bennetzen, M. V., Košař, M., Bunkenborg, J., Payne, M., Bártková, J., Lindström, M. S., Lukas, J., Andersen, J., Bártek, J., & Larsen, D. H. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1515552 · Cited by 10
“Understanding the behavior of nucleophosmin following IR is particularly important due to its ATM-dependent role in regulation of the tumor suppressor ARF with implications for treatment of advanced tumors [57].”
BackgroundThe relationship between defects in DNA repair genes and autoinflammatory diseases
Kıvanç, D., & Daşdemir, S. (2021) · Rheumatology International · doi:10.1007/s00296-021-04906-3 · Cited by 7
Wang, Z., Belghasem, M., Salih, E., Henderson, J., Igwebuike, C., Havasi, A., & Borkan, S. C. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00230.2020 · Cited by 6
p14ARF interacts with γ-H2AX and is involved in the DNA damage response
Huang, M., Zou, J., Luo, B., Sun, Y., Yang, Z., Huimin, K. O. N. G., Long, X., Sun, X., Yang, M., Wang, X., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151847 · Cited by 4
ATM: An unexpected tumor-promoting factor in HER2-expressing tumors
Stagni, V., Oropallo, V., & Barilà, D. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1054551 · Cited by 5
Yamamoto, Y. (2026) · Cancers · doi:10.3390/cancers18060932 · Cited by 4
“DNA damage response ( ATM , RB1 ) Preclinical novel mechanism (acquired resistance) [88] Notch signaling Hypothetical CSC maintenance mechanism [68–70] Abbreviations; CDK; cyclin-dependent kinase, CSC: cancer stem cell, EBC: early breast cancer, FGF: fibroblast growth factor, TGF: tumor forming…”
Wang, Z., Havasi, A., Beeler, A. B., & Borkan, S. C. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01696-8 · Cited by 3
“In interphase cells, NPM is a large, 185 kDa pentamer that interacts with chromatin by binding to nuclear histones and other chromatin remodeling proteins and cannot traverse the 50 kDa nuclear pore [32].”
BackgroundTavana, O., Chen, D., & Gu, W. J. (2014) · Cell Cycle · doi:10.4161/cc.27786 · Cited by 4
Self-citationVelimezi, G., Liontos, M., Vougas, K. N., Roumeliotis, T. I., Bártková, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M. K., Pateras, I. S., Evangelou, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2852 · Cited by 3
Self-citationInterpreting the Origins and Functions of Noncoding RNAs From the Ribosomal Genes
Moss, T., Sibai, D. S., & Lessard, F. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70080 · Cited by 2
“ARF regulation of TTF1 was also found to occur in both human and mouse cells (Lessard et al. 2010; Velimezi et al. 2013).”
Ambient NO2 induces premature pulmonary senescence in rats: The role of the ROS-DRG1/CDK5 axis
Ye, S., Luo, S., Tan, Y., Zhang, R., Ji, D., & Xiao, F. (2025) · Journal of Environmental Sciences · doi:10.1016/j.jes.2025.08.058 · Cited by 2
Oh, S., & Kim, H. S. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1233063 · Cited by 1
“PP1-siRNA) with mass spectrometry [30].”
p53-driven replication stress in nucleoli of malignant epithelial ovarian cancer
Guo, C. Y., Guo, L., Peng, C., Jia, Y., Yang, Y., Wang, X., Zeng, M., Wang, D., Liu, C., Zhao, M., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113225 · Cited by 1
In the race for protection, ARF comes second
Golomb, L., & Oren, M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.117 · Cited by 1
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Franqui-Machin, R., Colgan, J. D., Henry, M. D., Quelle, D. E., Habelhah, H., & Zhan, F. (2018) · doi:10.17077/etd.4d8c6hku · Cited by 1
Evolutionary conserved reciprocal senescence and tumor suppressor signals limit lifetime cancerPreprint
Liu, L., Davis, S. A., Yusuff, S., Strange, A., Zhuang, Y., Vaddi, P. K., Flaherty, K., Jara, K., Kramer, J., Archer, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.28.630560 · Cited by 1
MiR-signing gastrointestinal (con-)tract cancer
Gorgoulis, V. G., Pateras, I. S., & Kotsinas, A. (2017) · Oncotarget · doi:10.18632/oncotarget.15701
Self-citationGorgoulis, V. G., & Kotsinas, A. (2018) · BioEssays · doi:10.1002/bies.201800223
Self-citationEvangelou, K., & Gorgoulis, V. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_6698 · Cited by 1
Self-citationMonsalve, D. M. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124182 · Cited by 1
Evangelou, K., & Gorgoulis, V. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-21573-6_6698-1
Self-citationEltrombopag Inhibited Liver Cancer by Enhancing SMYD4 Protein Degradationvia TRIP12 Ubiquitinase
Li, J., Zhang, Q., Wang, C., & Liu, S. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400372
Diverse Forms of Autophagy and Their Roles in Liver Disease and Aging: A Comprehensive Review
Heo, S., Lee, M. Y., Jeong, C. Y., Kim, D. J., & Jun, J. H. (2026) · Proteomes · doi:10.3390/proteomes14020028
“Previous studies have reported a finely tuned regulatory system in human cancer model cells in which ATM suppresses ARF levels, while inactivation of ATM unmasks the tumor-suppressive effects of ARF [21].”
Metadata
- Authors
- Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., Kotsinas, A., Orsolic, I., Bursac, S., Cokaric-Brdovcak, M., Zoumpourlis, V., Kletsas, D., Papafotiou, G., Klinakis, A., Volarevic, S., Gu, W., Bartek, J., Halazonetis, T. D., & Gorgoulis, V. G.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Biomedical Research Foundation of the Academy of Athens (GR)
- University of Geneva (CH)
- Danish Cancer Society (DK)
- National Hellenic Research Foundation (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Columbia University (US)
- Corresponding author
- Gorgoulis, Vassilis G.
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2013-07-14
- Volume
- 15
- Issue
- 8
- Pages
- 967-977
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2039467788
- Cited by
- 131
- References
- 75
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 14 · 2017: 11 · 2016: 28 · 2015: 14 · 2014: 20 · 2013: 5
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-10-01)
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ATM kinase, DNA damage response, tumor suppression, protein phosphatase 1, NEK2, protein degradation, oncogene-transformed cells, carcinogenesis, ATM inhibition
- MeSH terms
- NIMA-Related Kinases, Animals, Carrier Proteins, Cell Cycle, Cell Line, DNA-Binding Proteins, HeLa Cells, Humans, Male, Neoplasms, Phosphorylation, Ribosomes, Transplantation, Heterologous, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Cell Cycle Proteins, ADP-Ribosylation Factor 1, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Protein Stability, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.